Related Experiment Video
Updated: May 3, 2026

05:39
Shock Wave Application to Cell Cultures
Published on: April 8, 2014
13.4K
Low-intensity shockwave therapy for erectile dysfunction: An abridged Cochrane review
Onuralp Ergun1,2, Kwangmin Kim3, Myung Ha Kim4
1Department of Urology, University of Minnesota, Minneapolis, MN, USA.
BJU International
|March 30, 2026
Summary
Low-intensity shockwave therapy (LiSWT) may improve erectile function and penile rigidity in men with erectile dysfunction (ED). However, the evidence certainty is low, and clinical importance remains uncertain.
Area of Science:
- Urology
- Andrology
- Regenerative Medicine
Background:
- Erectile dysfunction (ED) is a common condition affecting men's health.
- Current treatments for ED have limitations and potential side effects.
Purpose of the Study:
- To evaluate the efficacy and safety of low-intensity shockwave therapy (LiSWT) for treating ED.
- To compare LiSWT with sham therapy in randomized controlled trials (RCTs).
Main Methods:
- Systematic review and meta-analysis of 21 RCTs involving 1357 men.
- Inclusion criteria focused on LiSWT versus sham therapy for ED.
- Outcomes assessed included erectile function, rigidity, discontinuation rates, and adverse events.
Main Results:
- LiSWT showed a potential slight improvement in short-term erectile function (low-certainty evidence).
- Long-term erectile function may also improve, though with significant heterogeneity (low-certainty evidence).
- No significant differences were observed in discontinuation rates or adverse events between LiSWT and sham therapy.
Conclusions:
- Low-intensity shockwave therapy may offer benefits for long-term erectile function and short-term penile rigidity in men with ED.
- The certainty of evidence is low, necessitating cautious interpretation.
- Further high-quality research is needed to confirm the clinical significance and long-term effects of LiSWT for ED.
Keywords:
erectile dysfunctionextracorporeal shockwave therapypatient satisfactionquality of liferandomised controlled trialstreatment outcomeMore Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
823
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
823
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
Male Sexual Response: Erection & Ejaculation
31.3K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
31.3K
Electroconvulsive Therapy
2.6K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.6K

